Abstract

In prokaryotic type II topoisomerases (DNA gyrases), mutations that result in resistance to quinolones frequently occur at Ser83 or Ser84 of the gyrA subunit. Mutations to Trp, Ala, and Leu have been identified, all of which confer high levels of quinolone resistance. Extensive segments of DNA gyrase are homologous to eukaryotic topoisomerase II, and Ser741 of yeast TOP2 is homologous to Ser83 of prokaryotic DNA gyrA. Introduction of the Ser741-->Trp mutation into yeast TOP2 confers resistance to 6,8-difluoro-7-(4'-hydroxyphenyl)-1-cyclopropyl- 4-quinolone-3-carboxylic acid (CP-115,953), a fluoroquinolone with substantial activity against eukaryotic topoisomerase II, whereas changing Ser741 to either Leu or Ala does not change sensitivity to quinolones. Interestingly, Ser741-->Trp in the yeast TOP2 also confers hypersensitivity to etoposide. Sensitivity to intercalating anti-topoisomerase II agents such as amsacrine is not changed by any of the three mutations. The topoisomerase II protein carrying the Ser741-->Trp mutation was overexpressed and purified. The purified mutant enzyme had enhanced levels of etoposide stabilized covalent complex as compared with the wild type enzyme and reduced cleavage with CP-115,953. Unlike the wild type enzyme, etoposide-stabilized cleavage is not readily reversible by heat. We suggest that Ser741 is near a binding site for both quinolones and etoposide and that the Ser741-->Trp mutation leads to a more stable ternary complex between etoposide, DNA, and the mutant enzyme.

Highlights

  • We have found that the Ser74 1 ~ Trp mutation results in resistance to quinolones that act against eukaryotic topoisomerase II

  • Strains Carrying the Ser74 1 --> Trp Mutation in Yeast Topoisomerase II Are Resistant to CP-115,953 and Hypersensitive to Etoposide in Vivo-We constructed mutations in the yeast TOP2 gene by oligonucleotide-directed mutagenesis at Ser74 1, the amino acid homologous to Ser83 ofgyrA

  • The strains were converted to rad52, and the resulting strains were tested for sensitivity to the fluoroquinolone CP-115,953

Read more

Summary

Introduction

In prokaryotic type II topoisomerases (DNA gyrases), mutations that result in resistance to quinolones frequently occur at Ser or Ser of the gyrA subunit. Introduction of the Ser7 4 1 -> Trp mutation into yeast TOP2 confers resistance to 6,8-difluoro·7-(4' -hydroxyphenyl)-l-cyclopropyl-4.quinolone-3.carboxylic acid (CP-115,953), a fluoroquinolone with substantial activity against eukaryotic topoisomerase II, whereas changing Ser to either Leu or Ala does not change sensitivity to quinolones. DNA topoisomerases play essential roles in a wide range of DNA metabolic processes [1] Studies in both prokaryotic and eukaryotic cells have demonstrated their importance in transcription, DNA replication, and chromosome segregation [2]. The type II topoisomerases, which make transient double strand breaks and change the linking number of DNA in steps of two, play key roles in chromosome structure. The ability of the enzyme to pass two DNA strands and change linking number in steps of two uniquely allows this class of enzyme to segregate fully replicated DNA molecules prior to cell division (reviewed in Refs. 5 and 6)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.